- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Diagnosticos da America SA (DASA3)
Diagnosticos da America SA stock price live, this page displays BVMF DASA3 stock exchange data. View the DASA3 premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Diagnosticos da America SA real time stock price chart below.
What Is the Diagnosticos da America SA Stock Price Today?
The Diagnosticos da America SA stock price today is 3.88.
What Is the Stock Symbol for Diagnosticos da America SA?
The stock symbol for Diagnosticos da America SA is "DASA3."
What Stock Exchange Does Diagnosticos da America SA Trade On?
Diagnosticos da America SA is listed and trades on the B3 stock exchange.
Is Diagnosticos da America SA a Good Stock to Buy?
Determining whether Diagnosticos da America SA—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the DASA3 quote. (ISIN: BRDASAACNOR1)
What Is the Diagnosticos da America SA Stock Price Today?
The Diagnosticos da America SA stock price today is 3.88.
What Is the Stock Symbol for Diagnosticos da America SA?
The stock symbol for Diagnosticos da America SA is "DASA3."
What Stock Exchange Does Diagnosticos da America SA Trade On?
Diagnosticos da America SA is listed and trades on the B3 stock exchange.
Is Diagnosticos da America SA a Good Stock to Buy?
Determining whether Diagnosticos da America SA—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the DASA3 quote. (ISIN: BRDASAACNOR1)
3.88
+0.22(+6.01%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
3.65
3.88
52 wk Range
1.18
4.77
DASA3 is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
3.653.88
52 wk Range
1.184.77
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
DASA3 Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Neutral
Analysts Sentiment
Neutral
Price Target
2.91
Downside
-24.97%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Trading at a low Price / Book multiple
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy
Diagnosticos da America SA Company Profile
Diagnósticos da América S.A., together with its subsidiaries, provides diagnostic and hospital services in Brazil and Argentina. It operates through Hospitals and Oncology; Diagnostics and Care Coordination; and International Diagnostics segments. The company offers outpatient doctors; medical and outpatient services; diagnostic support assistants for private patients or partner companies; care coordination, remote monitoring, population health management, home medical, and paramedical services; and medical consultations. It is also involved in the development and licensing of computer programs and predictive models using information technology and data science; and brokerage activities. The company was formerly known as Laboratório Clínico Delboni Auriemo S.A. and changed its name to Diagnósticos da América S.A. in August 2000. Diagnósticos da América S.A. was founded in 1961 and is headquartered in Barueri, Brazil.
Diagnosticos da America SA Earnings Call Summary for Q3/2025
- DASA reported R$2.9 billion in consolidated revenue with 13% growth in diagnostics segment, driving stock price up 19.79% to 1.92 post-announcement.
- Significant margin improvements with gross margin up 5 percentage points and EBITDA margin increasing 7.6 percentage points, alongside 131% growth in operational cash generation.
- Cash conversion cycle reduced to 27 days as cash generation becomes a strategic pillar, with the company expanding its premium segment in key markets.
- Management projects EBITDA margin of 20-22% and modest EPS improvement by FY 2026, while focusing on operational efficiency despite potential market saturation risks.
Last Updated: 2025-11-14, 01:08 p/m
Read Full TranscriptCompare DASA3 to Peers and Sector
Metrics to compare | DASA3 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipDASA3PeersSector | |
|---|---|---|---|---|
P/E Ratio | −4.6x | 12.7x | −0.6x | |
PEG Ratio | −0.10 | 0.00 | 0.00 | |
Price/Book | 0.6x | 1.2x | 2.6x | |
Price / LTM Sales | 0.4x | 0.8x | 3.4x | |
Upside (Analyst Target) | −34.4% | 21.1% | 42.0% | |
Fair Value Upside | Unlock | 27.8% | 5.8% | Unlock |
Analyst Ratings
1 Buy
7 Hold
1 Sell
Ratings:
9 analysts
Overall Consensus
Neutral
Analysts 12-Month Price Target:
Average 2.91
(-24.97% Downside)
Earnings
Latest Release
Nov 13, 2025
EPS / Forecast
0.07 / -0.074
Revenue / Forecast
2.61B / 2.49B
People Also Watch
FAQ
What Is the DASA ON (DASA3) Stock Price Today?
The DASA ON stock price today is 3.88
What Stock Exchange Does DASA ON Trade On?
DASA ON is listed and trades on the B3 Stock Exchange stock exchange.
What Is the Stock Symbol for DASA ON?
The stock symbol for DASA ON is "DASA3."
What Is the DASA ON Market Cap?
As of today, DASA ON market cap is 4.79B.
What Is DASA ON's Earnings Per Share (TTM)?
The DASA ON EPS (TTM) is -0.63.
When Is the Next DASA ON Earnings Date?
DASA ON will release its next earnings report on Mar 26, 2026.
From a Technical Analysis Perspective, Is DASA3 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.
How Many Times Has DASA ON Stock Split?
DASA ON has split 2 times.
How Many Employees Does DASA ON Have?
DASA ON has 18142 employees.
What is the current trading status of DASA ON (DASA3)?
As of Jan 22, 2026, DASA ON (DASA3) is trading at a price of 3.88, with a previous close of 3.66. The stock has fluctuated within a day range of 3.65 to 3.88, while its 52-week range spans from 1.18 to 4.77.
What Is DASA ON (DASA3) Price Target According to Analysts?
The average 12-month price target for DASA ON is BRL2.91, with a high estimate of BRL6 and a low estimate of BRL1. 1 analysts recommend buying the stock, while 1 suggest selling, leading to an overall rating of Neutral. The stock has an -24.97% Downside potential.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.